Main navigation
You are here
- Home
- Investors
- Presentations & webcasts
2002 Presentations
30 January 2003
2002 full year results presentation
7 November 2002
2002 annual business review
R&D pipeline table - (PDF 106 kb)
Cardiovascular slides - (PDF 481 kb)
Discovery slides - (PDF 319 kb)
Oncology slides - (PDF 2,550 kb)
Portfolio slides - (PDF 248 kb)
30 January 2003
2002 full year results presentation
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceStock symbol - AZN
On LSE, NYSE and OMX
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
